Skip to main content

What McKesson's Quarter ended Sep 30, 2026 10-Q says: 8 signals

McKesson filed its latest 10-Q with the SEC on Nov 4, 2026. It discusses acquisition completed, automation investment and debt refinancing.

Public (MCK)Hospitals and Health Care10,000+ employeesmckesson.comLinkedIn

Get McKesson's live signals in Claude or ChatGPT, or by API

AskWhat changed at McKesson this week? Use Autobound signals for mckesson.com.
Filed
Nov 4, 2026
Period
Quarter ended Sep 30, 2026
Filings
3
Signals
19

Source: Autobound Signal API · 49 signals tracked for McKesson · updated

10-Q · latest 10

What McKesson's 10-Q filings say

  1. 10-Q · Quarter ended Sep 30, 2026

    Filed · 8 signals

    SEC EDGAR
  2. 10-Q · Quarter ended Jun 30, 2026

    Filed · 5 signals

    SEC EDGAR

Earlier 10-Q filings

  • 10-Q · Quarter ended Dec 31, 2025Filed · 6 signalsSEC EDGAR

Showing 10 of 19 filing signals. The Signal API returns all of them.

Get them with one API call

Earnings calls

McKesson earnings headlines

From earnings call transcripts (Signal API type earnings-transcripts).

Earnings call headlines
Call dateWhat the company said
Acquired Precision Medicine Group for approximately $2.25BThe company closed its acquisition of Precision Medicine Group for $2.25 billion in cash to scale clinical trial capabilities in oncology, rare diseases, and cell/gene therapies. PMG will be integrated into the Oncology and Multispecialty segment, contributing an estimated $0.10 to $0.20 of adjusted EPS in FY27.
Revenue grew 8% to $111B, operating profit up 13%Consolidated second-quarter revenue grew 8% year-over-year to $111 billion with increases across all four operating segments. Gross profit expanded 10% to $3.9 billion while adjusted operating profit climbed 13% to $1.9 billion, demonstrating strong operational leverage.
Raised fiscal 2027 adjusted EPS outlook to $45.60-$46.40Management increased full-year fiscal 2027 adjusted diluted EPS guidance to $45.60-$46.40 from the prior target of $44.20-$45.00, implying 17% to 19% adjusted EPS growth. The company expects consolidated revenue growth of 6% to 10% and operating profit growth of 12% to 16%.
Agreed to invest $1.4B for 49% stake in Option Care HealthA definitive agreement was signed to invest approximately $1.4 billion for a 49% minority interest in Option Care Health alongside majority owner CD&R. The transaction expands reach into home and alternate-site infusion therapy services and will be accounted for under the equity method.
GLP-1 distribution revenues reached $16B, climbing 26%North American Pharmaceutical GLP-1 medication distribution generated $16 billion in revenue during Q2, expanding 26% year-over-year ($3 billion) and 8% sequentially. Growth reflects persistent high demand and expanding utilization across health systems and retail channels.
Prism Vision Group expanded Mid-Atlantic footprint via Spectrum acquisitionThe company expanded its ophthalmology and retina platform by adding Spectrum Vision Partners and its 150+ providers to Prism Vision Group. This expansion strengthens provider platform scale across the Mid-Atlantic region.

Signal API · MCP

Track McKesson with the Signal API

One POST /v1/companies/enrich call with mckesson.com returns McKesson 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"mckesson.com","signal_types":["sec-10q"],"limit":20}'

Bulk data

Need this signal for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real 10-Q Filings records, as a CSV.

Talk to sales

Same industry

Questions about McKesson 10-Q

When did McKesson file its latest 10-Q?
McKesson filed its latest 10-Q (Quarter ended Sep 30, 2026) on Nov 4, 2026. The one before it was filed on Aug 5, 2026.
What did McKesson disclose in its latest 10-Q?
From the filing dated Nov 4, 2026: McKesson enters $5.0 billion senior unsecured credit facility and Medical-Surgical enters $3.2 billion term loans
What did McKesson say on its recent earnings calls?
Q2 FY2027: Acquired Precision Medicine Group for approximately $2.25B (dated Nov 4, 2026).
Where can I read McKesson's 10-Q filing?
The full filing is on SEC EDGAR: https://www.sec.gov/Archives/edgar/data/927653/000092765326000281/mck-20260930.htm. This page summarizes what the filing says and links to it.

Page updated , the date of the newest row on this page.

Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.

Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.

Data as of .

How this data is built →Get it from the Signal API →